Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Apex Healthcare | Kuala Lumpur | Healthcare | Pharmaceuticals | MYR 1.72B | 20.7x | -0.26 | MYR 2.39 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 17.2% Upside | Upgrade to Pro+ | |
Duopharma Biotech | Kuala Lumpur | Healthcare | Pharmaceuticals | MYR 1.19B | 21.4x | -2.3 | MYR 1.24 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 17.6% Upside | Upgrade to Pro+ | |
Amway | Kuala Lumpur | Healthcare | Pharmaceuticals | MYR 1.13B | 9.2x | 0.61 | MYR 6.85 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 4% Upside | Upgrade to Pro+ | |
Kotra Industries | Kuala Lumpur | Healthcare | Pharmaceuticals | MYR 674.83M | 16.6x | -0.5 | MYR 4.55 | 2.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 19.2% Upside | Upgrade to Pro+ | |
Pharmaniaga Bhd | Kuala Lumpur | Healthcare | Pharmaceuticals | MYR 468.40M | 5.1x | 0.04 | MYR 0.32 | -1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 18.2% Upside | Upgrade to Pro+ | |
YSP Southeast Asia | Kuala Lumpur | Healthcare | Pharmaceuticals | MYR 321.99M | 11.2x | -0.62 | MYR 2.27 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Rhone Ma | Kuala Lumpur | Healthcare | Pharmaceuticals | MYR 147.12M | 11.9x | 1.85 | MYR 0.67 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 5.3% Upside | Upgrade to Pro+ | |
Bioalpha | Kuala Lumpur | Healthcare | Pharmaceuticals | MYR 84.39M | -1.9x | -0.11 | MYR 0.06 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |